Hepatitis C Virus and Nonalcoholic Fatty Liver Disease: Similar Risk Factors for Necroinflammation, Fibrosis, and Cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 1, 2010, Pages 97-

  Comparcola, Donatella ^a   Alisi, Anna ^a   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ETHNICITY; GENOTYPE; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LETTER; LIFESTYLE MODIFICATION; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; METABOLIC DISORDER; METABOLIC SYNDROME X; NECROINFLAMMATION; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; STEATOSIS; VIRUS ACTIVATION; VIRUS LOAD;

FATTY LIVER; FIBROSIS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; NECROSIS; RISK FACTORS;

EID: 72049125105     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.09.005     Document Type: Letter

References (3)

1. Kallwitz E.R., Layden-Almer J., Dhamija M., et al. Ethnicity and body mass index are associated with hepatitis C presentation and progression. Clin Gastroenterol Hepatol 8 (2010) xxx-xxx
2. Hanouneh I.A., Feldstein A.E., Lopez R., et al. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 6 (2008) 584-589
3. Balsano C., Alisi A., and Nobili V. Liver fibrosis and therapeutic strategies: the goal for improving metabolism. Curr Drug Targets 10 (2009) 505-512